title: Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production.
abstract: During the replication of influenza viruses, defective interfering particles (DIPs) can be generated. These are noninfectious deletion mutants that require coinfection with a wild-type virus but interfere with its helper virus replication. Consequently, coinfected cells mainly produce DIPs. Little is known about how such noninfectious virus particles affect the virus yield of cell culture-based influenza vaccine production. We compared infections of Madin-Darby canine kidney cells with two seed virus preparations of the influenza virus strain A/Puerto Rico/8/34 that contain different amounts of DIPs. A combination of conventional RT-PCR, RT-qPCR, and flow cytometry revealed that DI genomes indeed strongly accumulate in coinfected cells and impede the viral RNA synthesis. Additionally, cells infected at the higher DIP concentration showed a stronger antiviral response characterized by increased interferon-β expression and apoptosis induction. Furthermore, in the presence of DIPs, a significant fraction of cells did not show any productive accumulation of viral proteins at all. Together, these effects of DIPs significantly reduce the virus yield. Therefore, the accumulation of DIPs should be avoided during influenza vaccine production which can be achieved by quality controls of working seed viruses based on conventional RT-PCR. The strategy for the depletion of DIPs presented here can help to make cell culture-based vaccine production more reliable and robust.
authors.affiliation: Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Sandtorstrasse 1, 39106, Magdeburg, Germany, frensing@mpi-magdeburg.mpg.de.
authors.forename: Timo
authors.initials: T
authors.lastname: Frensing
authors.forename: Antje
authors.initials: A
authors.lastname: Pflugmacher
authors.forename: Mandy
authors.initials: M
authors.lastname: Bachmann
authors.forename: Britta
authors.initials: B
authors.lastname: Peschel
authors.forename: Udo
authors.initials: U
authors.lastname: Reichl
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000378:metabolism; D017209:Apoptosis; D003673:Defective Viruses / Q000502:physiology*; D004285:Dogs; D005434:Flow Cytometry; D054884:Host-Pathogen Interactions; D009980:Influenza A virus / Q000254:growth & development / Q000276:immunology* / Q000502:physiology*; D007252:Influenza Vaccines / Q000302:isolation & purification*; D007372:Interferons / Q000378:metabolism; D061985:Madin Darby Canine Kidney Cells; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D019562:Viral Load; D014779:Virus Replication
chemical_list: D000998:Antiviral Agents; D007252:Influenza Vaccines; D007372:Interferons